Abstract

Publisher Summary Disturbances in the serum potassium concentration are some of the most common metabolic side effects associated with the use of diuretics. Those agents that act proximal to the collecting duct are associated with hypokalemia. The development of hypokalemia is primarily the result of diuretic-induced changes in extracellular fluid (ECF) volume, mineralocorticoid activity, and distal sodium delivery. These alterations lead to enhanced potassium excretion at sites distal to where the drug exerts its diuretic effect. Diuretics that act at the level of the collecting duct are associated with hyperkalemia and are commonly referred to as potassium sparing diuretics. These agents predispose to the development of hyperkalemia by disturbing potassium transport mechanisms localized in the collecting duct. This chapter reviews both the direct and the indirect mechanisms by which diuretics disturb normal potassium homeostasis. The clinical consequences of these disturbances are also discussed. To provide a better understanding of how diuretics lead to disturbances in the serum potassium concentration, a brief overview of renal potassium handling is also presented.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.